1. Home
  2. SBFM vs JWEL Comparison

SBFM vs JWEL Comparison

Compare SBFM & JWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • JWEL
  • Stock Information
  • Founded
  • SBFM 2006
  • JWEL 2012
  • Country
  • SBFM United States
  • JWEL China
  • Employees
  • SBFM N/A
  • JWEL N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • JWEL Other Consumer Services
  • Sector
  • SBFM Health Care
  • JWEL Consumer Discretionary
  • Exchange
  • SBFM Nasdaq
  • JWEL Nasdaq
  • Market Cap
  • SBFM 3.7M
  • JWEL 4.1M
  • IPO Year
  • SBFM N/A
  • JWEL 2021
  • Fundamental
  • Price
  • SBFM $2.35
  • JWEL $1.95
  • Analyst Decision
  • SBFM
  • JWEL
  • Analyst Count
  • SBFM 0
  • JWEL 0
  • Target Price
  • SBFM N/A
  • JWEL N/A
  • AVG Volume (30 Days)
  • SBFM 151.4K
  • JWEL 16.1K
  • Earning Date
  • SBFM 11-05-2024
  • JWEL 11-29-2024
  • Dividend Yield
  • SBFM N/A
  • JWEL N/A
  • EPS Growth
  • SBFM N/A
  • JWEL N/A
  • EPS
  • SBFM N/A
  • JWEL N/A
  • Revenue
  • SBFM $32,959,491.00
  • JWEL $160,009,293.00
  • Revenue This Year
  • SBFM $86.70
  • JWEL N/A
  • Revenue Next Year
  • SBFM $126.76
  • JWEL N/A
  • P/E Ratio
  • SBFM N/A
  • JWEL N/A
  • Revenue Growth
  • SBFM 61.94
  • JWEL N/A
  • 52 Week Low
  • SBFM $2.25
  • JWEL $1.00
  • 52 Week High
  • SBFM $638.00
  • JWEL $3.14
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 25.54
  • JWEL 54.81
  • Support Level
  • SBFM $2.58
  • JWEL $1.81
  • Resistance Level
  • SBFM $2.86
  • JWEL $2.15
  • Average True Range (ATR)
  • SBFM 0.17
  • JWEL 0.18
  • MACD
  • SBFM -0.04
  • JWEL 0.01
  • Stochastic Oscillator
  • SBFM 12.67
  • JWEL 49.09

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

About JWEL Jowell Global Ltd.

Jowell Global Ltd is a cosmetics, health and nutritional supplements, and household products e-commerce platform. It operates under Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing sales channels. The company's major merchandise categories are Cosmetic products, Health and nutritional supplements, and Household Products.

Share on Social Networks: